Department of Head and Neck and Comprehensive Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu UniversityZhenjiang, P. R. China
Department of Head and Neck and Comprehensive Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu UniversityZhenjiang, P. R. China
Department of Head and Neck and Comprehensive Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu UniversityZhenjiang, P. R. China
This work is licensed under the Creative Commons Attribution 4.0 International License.
He J, Chen WQ, Li ZS, Li N, Ren JS, Tian JH, et al. [China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2022; 44: 491-522. doi: 10.3760/cma.j.cn112152-20220517-00348HeJChenWQLiZSLiNRenJSTianJH[China guideline for the screening early detection and early treatment of esophageal cancer (2022, Beijing)]. [Chinese]. Zhonghua Zhong Liu Za Zhi2022; 44: 491-522. doi: 10.3760/cma.j.cn112152-20220517-00348Open DOISearch in Google Scholar
Li S, Chen H, Man J, Zhang T, Yin X, He Q, et al. Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med 2021; 10: 1889-99. doi: 10.1002/cam4.3775LiSChenHManJZhangTYinXHeQChanging trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med2021; 10: 1889-99. doi: 10.1002/cam4.3775Open DOISearch in Google Scholar
Early Diagnosis and treatment group of the Chinese Medical Association Oncology Branch. [Chinese expert consensus on early diagnosis and treatment of esophageal cancer]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2022; 44: 1066-75. doi: 10.3760/cma.j.cn112152-20220220-00114Early Diagnosis and treatment group of the Chinese Medical Association Oncology Branch. [Chinese expert consensus on early diagnosis and treatment of esophageal cancer]. [Chinese]. Zhonghua Zhong Liu Za Zhi2022; 44: 1066-75. doi: 10.3760/cma.j.cn112152-20220220-00114Open DOISearch in Google Scholar
National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018. Chin J Cancer Res 2019; 31: 223-58. doi: 10.21147/j.issn.1000-9604.2019.02.01National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018. Chin J Cancer Res2019; 31: 223-58. doi: 10.21147/j.issn.1000-9604.2019.02.01Open DOISearch in Google Scholar
Shi Z, Zhu X, Ruan C, Wei G, Li J, Qiu H, et al. Evaluation of concurrent chemoradiotherapy for survival outcomes in patients with synchronous oligometastatic esophageal squamous cell carcinoma. JAMA Netw Open 2022; 5: e2244619. doi: 10.1001/jamanetworkopen.2022.44619ShiZZhuXRuanCWeiGLiJQiuHEvaluation of concurrent chemoradiotherapy for survival outcomes in patients with synchronous oligometastatic esophageal squamous cell carcinoma. JAMA Netw Open2022; 5: e2244619. doi: 10.1001/jamanetworkopen.2022.44619Open DOISearch in Google Scholar
Luo D, Zhong Q, Yue H, Wang J, Liang Q, Liu W, et al. The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma. Cancer Biol Ther 2024; 25: 2371632. doi: 10.1080/15384047.2024.2371632LuoDZhongQYueHWangJLiangQLiuWThe predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma. Cancer Biol Ther2024; 25: 2371632. doi: 10.1080/15384047.2024.2371632Open DOISearch in Google Scholar
Cinicola J, Mamidanna S, Yegya-Raman N, Spencer K, Deek MP, Jabbour SK. A review of advances in radiotherapy in the setting of esophageal cancers. Surg Oncol Clin N Am 2023; 32: 433-59. doi: 10.1016/j.soc.2023.03.004CinicolaJMamidannaSYegya-RamanNSpencerKDeekMPJabbourSK.A review of advances in radiotherapy in the setting of esophageal cancers. Surg Oncol Clin N Am2023; 32: 433-59. doi: 10.1016/j.soc.2023.03.004Open DOISearch in Google Scholar
Wang X, Wang P, Huang X, Han Y, Zhang P. Biomarkers for immunotherapy in esophageal cancer. Front Immunol 2023; 14: 1117523. doi: 10.3389/fimmu.2023.1117523WangXWangPHuangXHanYZhangP.Biomarkers for immunotherapy in esophageal cancer. Front Immunol2023; 14: 1117523. doi: 10.3389/fimmu.2023.1117523Open DOISearch in Google Scholar
Suzuki R, Lin SH, Wei X, Allen PK, Welsh JW, Byers LA, et al. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Radiother Oncol 2018; 126: 499-505. doi: 10.1016/j.radonc.2017.12.030SuzukiRLinSHWeiXAllenPKWelshJWByersLAPrognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Radiother Oncol2018; 126: 499-505. doi: 10.1016/j.radonc.2017.12.030Open DOISearch in Google Scholar
Cox S, Hurt C, Grenader T, Mukherjee S, Bridgewater J, Crosby T. The prognostic value of derived neutrophil to lymphocyte ratio in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 2017; 125: 154-9. doi: 10.1016/j.radonc.2017.08.023CoxSHurtCGrenaderTMukherjeeSBridgewaterJCrosbyT.The prognostic value of derived neutrophil to lymphocyte ratio in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol2017; 125: 154-9. doi: 10.1016/j.radonc.2017.08.023Open DOISearch in Google Scholar
Huang D, Zhu XZ, Sheng WQ. [2019 updates of the WHO classification of the digestive system tumors, part: epithelial neoplasms in gastrointestinal tract]. [Chinese]. Zhonghua Bing Li Xue Za Zhi 2020; 49: 209-13. doi: 10.3760/cma.j.issn.0529-5807.2020.03.001HuangDZhuXZShengWQ.[2019 updates of the WHO classification of the digestive system tumors part: epithelial neoplasms in gastrointestinal tract]. [Chinese]. Zhonghua Bing Li Xue Za Zhi2020; 49: 209-13. doi: 10.3760/cma.j.issn.0529-5807.2020.03.001Open DOISearch in Google Scholar
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-4. doi: 10.1001/jama.2013.281053World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA2013; 310: 2191-4. doi: 10.1001/jama.2013.281053Open DOISearch in Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026EisenhauerEATherassePBogaertsJSchwartzLHSargentDFordRNew response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026Open DOISearch in Google Scholar
Wang H, Lan L, Chen J, Xiao L, Han F. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients. Lupus Sci Med 2022; 9: e000717. doi:10.1136/lupus-2022-000717WangHLanLChenJXiaoLHanF.Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients. Lupus Sci Med2022; 9: e000717. doi:10.1136/lupus-2022-000717Open DOISearch in Google Scholar
Khan J, Lieberman JA, Lockwood CM. Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs. Clin Chem Lab Med 2017; 55: 608-21. doi: 10.1515/cclm-2016-0471KhanJLiebermanJALockwoodCM.Variability in variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs. Clin Chem Lab Med2017; 55: 608-21. doi: 10.1515/cclm-2016-0471Open DOISearch in Google Scholar
Zegels G, Van Raemdonck GA, Tjalma WA, Van Ostade XW. Use of cervicov-aginal fluid for the identification of biomarkers for pathologies of the female genital tract. Proteome Sci 2010; 8: 63. doi: 10.1186/1477-5956-8-63ZegelsGVan RaemdonckGATjalmaWAVan OstadeXW.Use of cervicov-aginal fluid for the identification of biomarkers for pathologies of the female genital tract. Proteome Sci2010; 8: 63. doi: 10.1186/1477-5956-8-63Open DOISearch in Google Scholar
Pleil JD, Wallace MAG, Stiegel MA, Funk WE. Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates. J Toxicol Environ Health B Crit Rev 2018; 21: 161-80. doi: 10.1080/10937404.2018.1490128PleilJDWallaceMAGStiegelMAFunkWE.Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates. J Toxicol Environ Health B Crit Rev2018; 21: 161-80. doi: 10.1080/10937404.2018.1490128Open DOISearch in Google Scholar
Zhang J, Dasgupta A, Ayala R, Bonapace C, Kassim S, Faustino PJ. Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations. Bioanalysis 2024; 16: 771-6. doi: 10.1080/17576180.2024.2348939ZhangJDasguptaAAyalaRBonapaceCKassimSFaustinoPJ.Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations. Bioanalysis2024; 16: 771-6. doi: 10.1080/17576180.2024.2348939Open DOISearch in Google Scholar
Shao N, Cai Q. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Clin Transl Oncol 2015; 17: 772-8. doi: 10.1007/s12094-015-1289-8ShaoNCaiQ.High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Clin Transl Oncol2015; 17: 772-8. doi: 10.1007/s12094-015-1289-8Open DOISearch in Google Scholar
Shao B, Li H, Liu X, Song G, Jiang H, Yan Y, et al. The prognostic value of neu-trophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study. Ann Transl Med 2023; 11: 45. doi: 10.21037/atm-22-5612ShaoBLiHLiuXSongGJiangHYanYThe prognostic value of neu-trophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study. Ann Transl Med2023; 11: 45. doi: 10.21037/atm-22-5612Open DOISearch in Google Scholar
